Healthcare Stocks Under Shariah: Hospital Chains and Insurance Exposure

Healthcare seems like the cleanest sector for Shariah investing. Treating sick people, producing medicines, running hospitals. All classically permissible activities. What could go wrong?

Quite a lot, actually. When you run real healthcare stocks through Shariah screens, the results are messier than most investors expect. The main culprits are conventional insurance, interest-bearing receivables, and debt-heavy capital structures that hospital chains use to finance construction.

Let me walk through the healthcare sector's Shariah quirks.

Pharmaceutical companies: mostly clean

Large pharmaceutical manufacturers like Johnson & Johnson, Pfizer, Novartis, Roche, and Merck are generally Shariah-compliant on the business activity front. Making medicines, conducting research, and selling drugs are all permissible activities.

The complications tend to be:
- Debt levels (pharma companies often carry meaningful debt to fund R&D and acquisitions)
- Interest income from large cash piles
- Occasional non-permissible product lines (like alcohol-based hand sanitizers, although most scholars consider these incidental)
- Non-permissible R&D collaborations (rare)

Johnson & Johnson, for instance, has sometimes been flagged because of its consumer health segment that historically included various product lines with minor ethical concerns. The debate is usually about ancillary products, not the core pharmaceutical business.

Under most methodologies, the big pharmaceutical companies pass Shariah screens. Their debt ratios are manageable, their cash ratios are usually fine, and their primary business is clearly permissible.

Medical device companies: usually clean

Medical device makers like Medtronic, Stryker, Boston Scientific, and Abbott Laboratories are generally compliant on business activity. Making surgical tools, implantable devices, diagnostic equipment, and related technology is permissible.

The debt screen is where some device companies fail. Device companies are capital-intensive and often carry substantial debt from acquisitions. A device maker that has made a large recent acquisition might temporarily flunk the debt ratio, then return to compliance after the acquisition is integrated and debt is paid down.

Medtronic has had quarters where its debt ratio pushed against the threshold, particularly after its acquisition of Covidien in 2015 which added significant debt. The ratio normalized over several years.

Hospital chains: this is where it gets hard

Running a hospital is permissible. But running a for-profit hospital chain in the US or Europe comes with baggage that often disqualifies the company for Shariah purposes. Let me explain.

Issue 1: Debt levels. Building and operating hospitals is expensive. Hospital chains typically carry substantial debt from property construction, equipment financing, and acquisitions of other hospital systems. Debt-to-market-cap ratios of 40-60% are common in the sector. This alone kills many hospital chains for Shariah compliance.

Issue 2: Insurance partnerships. Most US hospital chains have preferred provider relationships with health insurance companies. Some hospital chains own health insurance subsidiaries. Even where they don't own insurance, they depend heavily on collecting payments from insurance providers. Some scholars have flagged this as creating indirect riba exposure because the entire revenue stream depends on conventional insurance economics.

Issue 3: Interest on receivables. Hospitals have enormous accounts receivable from patients and insurance companies. Some of this accrues interest or carries late payment fees. Under stricter Shariah screens, interest earned on overdue receivables counts as non-permissible income.

Issue 4: Financial services subsidiaries. Some hospital chains have set up financing arms to lend money to patients who can't afford out-of-pocket costs. These arms can generate interest income that fails the 5% non-permissible income screen.

HCA Holdings case study

HCA Holdings is the largest for-profit hospital operator in the US. Its balance sheet has historically been debt-heavy because of multiple private equity recapitalizations and ongoing facility investments.

Approximate HCA figures:
- Total interest-bearing debt: 40 billion
- Market cap: 80 billion
- Total assets: 55 billion

Debt ratio (market cap): 50%. Fail badly.
Debt ratio (total assets): 73%. Fail even worse.

HCA is non-compliant under every mainstream methodology because of debt alone. The business is permissible, but the capital structure is not. This is the structural problem that plagues for-profit hospital operators.

Tenet Healthcare case study

Tenet is similar to HCA in structural profile. Heavy debt from recapitalizations and acquisitions. Tenet's debt-to-market-cap ratio has often exceeded 100% because debt is close to total enterprise value. Fails all screens.

Most hospital chains look similar. The sector has a structural debt problem that makes Shariah compliance rare.

Non-profit hospital systems

Non-profit hospital systems (Cleveland Clinic, Mayo Clinic, Kaiser Permanente) aren't publicly traded, so they don't appear in Shariah screening at all. If they were publicly traded, their debt profiles and cash management might be cleaner because they don't have private equity recapitalization histories, but they'd still have hospital-specific issues.

Insurance companies: categorically excluded

Conventional health insurance companies are excluded from Shariah screening at the business activity layer. This includes UnitedHealth, Anthem (now Elevance Health), Cigna, Humana, and every other major health insurer in the US. The logic:

• Insurance uses pooling, uncertainty, and risk transfer models that classical scholars considered problematic under gharar (excessive uncertainty)
• Premium income is invested in interest-bearing securities, generating riba returns
• Policy structures involve elements of speculation

Takaful (Islamic insurance) exists as a permissible alternative, but no major publicly listed takaful company has the scale of a conventional US health insurer, so the comparison is limited.

UnitedHealth, which has a massive pharmacy benefits manager (OptumRx) and health services division (Optum) alongside its core insurance business, has been debated because some scholars argue that a substantial portion of UnitedHealth's profits now come from non-insurance services. The non-insurance share is significant but hasn't been enough to rescue UnitedHealth from the underlying insurance exposure in formal screens.

Pharmacy chains

Pharmacy chains like CVS Health and Walgreens Boots Alliance are complicated. The core pharmacy business (dispensing medicine) is permissible. But:

• CVS acquired Aetna in 2018, becoming a massive health insurer. This killed CVS's Shariah compliance under business activity screens.
• Walgreens has retail operations that include selling cigarettes (in most locations until recent years) and beer/wine in some countries, creating non-permissible revenue exposure. Walgreens has been slowly reducing tobacco sales but the legacy exposure is material.
• Both chains carry substantial debt from acquisitions and store expansion.

CVS is non-compliant under every methodology post-Aetna acquisition. Walgreens is borderline due to tobacco exposure and debt levels.

Biotech companies

Biotech is generally clean on business activity. Developing new drugs is permissible. The complications are:
- Many biotechs are unprofitable and rely heavily on equity financing (not a Shariah issue)
- Some biotechs have large cash positions from capital raises, which can trigger the liquidity ratio
- Research on stem cells, gene editing, and other frontier technologies has occasionally raised specific ethical questions (not methodology questions, but individual scholar opinions)

Most large biotechs (Amgen, Gilead Sciences, Regeneron, Vertex) pass Shariah screens because their financials are clean even when their research is at the frontier. The ethical questions about specific research types are outside the formal methodology framework.

Medical imaging and diagnostics

Companies making imaging equipment, laboratory diagnostics, and clinical testing services are generally permissible. GE Healthcare (now spun off from GE), Philips Healthcare, and Siemens Healthineers all do imaging work. Labcorp and Quest Diagnostics do clinical testing.

The debates are usually about debt levels and parent-company structure. GE Healthcare's compliance status was affected by GE's conglomerate structure before the spin-off. Philips has had debt ratio issues in certain years. Siemens Healthineers has been generally clean.

Veterinary care

Veterinary chains are an interesting subsector. Mars Inc. owns several (privately held). Publicly traded veterinary companies include IDEXX Laboratories (vet diagnostics) and a few specialty pet care chains.

Vet care is unambiguously permissible. The companies that fail Shariah screens in this subsector usually fail on debt ratios, not business activity.

The Reliance Industries connection

It's worth noting that Reliance (RELIANCE.NS) has entered the healthcare space in recent years through Reliance Jio's healthcare apps and hospital partnerships. This doesn't materially affect Reliance's Shariah screening because the healthcare operations are small relative to the core refining and telecom businesses, but it's an example of how large conglomerates are touching healthcare without becoming pure healthcare companies.

The takeaway for sector investors

If you want healthcare sector exposure in a Shariah portfolio, the cleanest paths are:

1. Large pharmaceutical manufacturers (Pfizer, Novartis, Roche, Merck, GSK, Sanofi) after checking debt ratios quarter by quarter
2. Medical device manufacturers (Medtronic, Stryker, Abbott) after checking debt
3. Profitable biotechs (Amgen, Gilead, Vertex) with clean business activity
4. Clinical diagnostics (Labcorp, Quest, IDEXX) with normal debt

Avoid:
- For-profit hospital operators (HCA, Tenet) due to debt
- Conventional health insurers (UnitedHealth, Elevance, Cigna) due to business activity
- Pharmacy-insurance hybrids (CVS) due to insurance exposure
- Tobacco-exposed retailers (historically Walgreens)

The sector is smaller for Shariah investors than it first appears. A lot of the household names are excluded. But what remains is substantial and represents some of the highest-quality businesses in the global equity universe.

FaithScreener categorizes healthcare stocks by subsector and shows you which subsectors have the cleanest compliance picture. For any individual stock, we show the specific reason for pass or fail so you understand whether it's business activity, debt, or another ratio driving the outcome. Healthcare is a sector where you need to look at the specific stock, not just the sector label, before assuming compliance.